Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 17, 2024, under its share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Shares Purchased: 645,140 ordinary shares
- Purpose: Cancellation under the Buyback Programme
- Highest Price Paid: 397.90 pence per share
- Lowest Price Paid: 394.80 pence per share
- Volume Weighted Average Price: 396.4085 pence per share
- Post-Transaction Share Capital: 9,117,826,432 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of the 645,140 purchased shares. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction. The filing notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the updated total share capital of 9,117,826,432 shares for disclosure threshold calculations.
- Review the full trade breakdown at the provided RNS link for intraday pricing details.
- Note that this filing does not contain financial performance data; refer to the most recent Form 20-F or quarterly earnings release for revenue and profit metrics.